The US FDA has warned Sanofi about deviations from cGMP for active pharmaceutical ingredients at their Genzyme manufacturing plant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback